Dugos, Baby Girl .
HRN: 22-87-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/18/2023
04/24/2023
IVT
300mg
Q12
Neonatal Sepsis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes